Detailed programme:
Time | Day 1 (Friday, 20 May 2005) | Day 2 (Saturday, 21 May 2005) |
0830 – 0930 | Plenary | |
Current Progress in The treatment of Adult Acute Myeloid Leukaemia (Prof. Newland) | ||
0930 - 1030 | Symposium 3 - Platelet disorders | |
ITP – investigation and novel therapy (Prof. Newland) | ||
HITS (Dr. Puru) | ||
1030 – 1100 | Tea | |
1100 – 1230 | Thrombotic thrombocytopenic purpura (Dr. Jameela) | |
Role of FVIIa in platelet disorders - ?Novo Nordisk (Chang to identify) | ||
1230 – 1400 | Registration (Leong and co.) | Lunch (1/2 hour for Pfizer) – Evolving treatment options for invasive fungal infections Prof. Deborah Mariott |
1400 – 1430 | Case studies | |
Penang – TBC | ||
GHKL – Dr. Ong | ||
HUKM – Dr. CF Leong | ||
HUSM – Prof Aziz Baba | ||
Ipoh Hospital – Dr. Padmini | ||
Panelist | ||
Dr. Puru | ||
Dr. Newland | ||
Dr. Leong K W | ||
Prof. Cheong | ||
1430 – 1545 | ||
Symposium 1 - Leukemia management | ||
CML and Glivec – Dr. Alan Teh | ||
Role of quantitative PCR – Dr. Veera | ||
Transplant in CML – Dr. Chang | ||
1545 - 1600 | Tea | Tea |
1600 – 1730 | Symposium 2 - Myeloma | |
Immunotherapy of MM – Dr. Fadilah | ||
Transplant and myeloma – Dr. MH Saw | ||
Amyloidosis – Prof. Looi | ||
1730 - 1830 | AGM | |